SalicylanilideAntiviral,antibacterial,antifungal reagent CAS# 87-17-2 |
- Calyculin A
Catalog No.:BCC2457
CAS No.:101932-71-2
- Calcineurin Autoinhibitory Peptide
Catalog No.:BCC2456
CAS No.:148067-21-4
- DL-AP3
Catalog No.:BCC2459
CAS No.:20263-06-3
- Ceramide
Catalog No.:BCC2458
CAS No.:3102-57-6
- Fostriecin sodium salt
Catalog No.:BCC2460
CAS No.:87860-39-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 87-17-2 | SDF | Download SDF |
PubChem ID | 6872 | Appearance | Powder |
Formula | C13H11NO2 | M.Wt | 213.23 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 170 mg/mL (797.26 mM; Need ultrasonic and warming) | ||
Chemical Name | 2-hydroxy-N-phenylbenzamide | ||
SMILES | C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2O | ||
Standard InChIKey | WKEDVNSFRWHDNR-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Salicylanilide Dilution Calculator
Salicylanilide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.6898 mL | 23.4489 mL | 46.8977 mL | 93.7954 mL | 117.2443 mL |
5 mM | 0.938 mL | 4.6898 mL | 9.3795 mL | 18.7591 mL | 23.4489 mL |
10 mM | 0.469 mL | 2.3449 mL | 4.6898 mL | 9.3795 mL | 11.7244 mL |
50 mM | 0.0938 mL | 0.469 mL | 0.938 mL | 1.8759 mL | 2.3449 mL |
100 mM | 0.0469 mL | 0.2345 mL | 0.469 mL | 0.938 mL | 1.1724 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Salicylanilides are a group of compounds with a wide range of biological activities including antiviral potency, antibacterial (including antimycobacterial) and antifungal activities.
- Thiolutin
Catalog No.:BCC2471
CAS No.:87-11-6
- TLQP 21
Catalog No.:BCC2405
CAS No.:869988-94-3
- MK-2048
Catalog No.:BCC2136
CAS No.:869901-69-9
- Alpinumisoflavone acetate
Catalog No.:BCN6813
CAS No.:86989-18-6
- VRT752271
Catalog No.:BCC4122
CAS No.:869886-67-9
- Radezolid
Catalog No.:BCC1882
CAS No.:869884-78-6
- Formoxanthone A
Catalog No.:BCN6451
CAS No.:869880-32-0
- Andropanolide
Catalog No.:BCN4559
CAS No.:869807-57-8
- A 841720
Catalog No.:BCC7550
CAS No.:869802-58-4
- threo-Guaiacylglycerol beta-coniferyl ether
Catalog No.:BCN1323
CAS No.:869799-76-8
- A-770041
Catalog No.:BCC1323
CAS No.:869748-10-7
- Obestatin (rat)
Catalog No.:BCC5912
CAS No.:869705-22-6
- Ac-DL-Trp-OH
Catalog No.:BCC3119
CAS No.:87-32-1
- Isosorbide dinitrate
Catalog No.:BCC9004
CAS No.:87-33-2
- trans-Caryophyllene
Catalog No.:BCN2644
CAS No.:87-44-5
- Gramine
Catalog No.:BCN4959
CAS No.:87-52-5
- Pyrogallol
Catalog No.:BCN4424
CAS No.:87-66-1
- Tartaric acid
Catalog No.:BCN3824
CAS No.:87-69-4
- D-Mannitol busulfan
Catalog No.:BCN3789
CAS No.:1187-00-4
- Inositol
Catalog No.:BCN8471
CAS No.:87-89-8
- xylitol pentacetate
Catalog No.:BCN6267
CAS No.:13437-68-8
- A 839977
Catalog No.:BCC4290
CAS No.:870061-27-1
- Tozadenant
Catalog No.:BCC2011
CAS No.:870070-55-6
- Apilimod mesylate
Catalog No.:BCC5287
CAS No.:870087-36-8
Synthesis of p-O-Alkyl Salicylanilide Derivatives as Novel EGFR Inhibitors.[Pubmed:26763193]
Drug Dev Res. 2016 Feb;77(1):37-42.
Preclinical Research Epidermal growth factor receptor (EGFR), a validated target for anticancer drugs, plays a critical role in tumorigenesis and tumor development. A series of p-O-alkyl Salicylanilide derivatives were designed and synthesized as novel EGFR inhibitors using a salicylic acid scaffold. A simulated six-membered ring strategy formed through intramolecular hydrogen bonds was employed to mimic the planar quinazoline of the EGFR antagonist, gefitinib. The derived compounds with hydroxyl at the ortho position were more potent than ones with methoxyl group. In particular, compounds 5d and 5b displayed significant EGFR inhibitory (IC50 values = 0.30 and 0.45 muM, respectively) activity as well as potent antiproliferative activity in A431 and HCT-116 tumor cells. These Salicylanilides could be considered as promising lead compounds for developing novel EGFR inhibitors.
Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.[Pubmed:26879856]
Bioorg Med Chem. 2016 Mar 15;24(6):1322-30.
The research of innovative antimicrobial agents represents a cutting edge topic. Hence, we synthesized and characterised novel Salicylanilide N-monosubstituted carbamates. Twenty compounds were evaluated in vitro against eight bacterial strains and eight fungal species. The lowest minimum inhibitory concentrations (MICs) were found to be 0.49 muM. Genus Staphylococcus, including methicillin-resistant Staphylococcus aureus, and fungus Trichophyton mentagrophytes showed uniformly the highest rate of susceptibility, whilst Gram-negative bacteria and most of the fungi were less susceptible. A wide range of carbamates provided comparable or superior in vitro antimicrobial activity in comparison to established drugs. Interestingly, extended-spectrum beta-lactamase producing strain of Klebsiella pneumoniae was inhibited with MICs starting from 31.25 muM. With respect to Staphylococci, 2-[(4-bromophenyl)carbamoyl]-4-chlorophenyl phenylcarbamate exhibited the lowest MIC values (0.98 muM). 2-[(4-Bromophenyl)carbamoyl]-4-chlorophenyl benzylcarbamate showed the widest spectrum of antifungal action. The results indicate that some Salicylanilide carbamates can be considered to be promising candidates for future investigation.